PGTA is especially recommended for individuals or couples with certain risk factors, including:

• Women over the age of 35
• Recurrent IVF failures
• History of repeated miscarriages
• Known chromosomal abnormalities in either parent
• Male factor infertility with high DNA fragmentation
• Couples undergoing IVF who wish to minimize the risk of genetic disorders

By identifying chromosomally normal embryos, PGTA offers peace of mind and improves the chances of delivering a healthy baby.

The PGTA process begins during a standard IVF cycle. After the eggs are fertilized and embryos reach the blastocyst stage (typically Day 5 or 6), a few cells are carefully biopsied from the outer layer of each embryo. These cells are then sent to a specialized genetics lab for analysis using advanced techniques such as Next Generation Sequencing (NGS).

Only embryos with the correct number of chromosomes (euploid embryos) are selected for transfer, reducing the likelihood of implantation failure or miscarriage.

At Kailash IVF, we combine state-of-the-art technology with personalized care to offer the best outcomes for every couple. Here's why hopeful parents trust us:

• Expertise You Can Rely On
  Our team of experienced embryologists and fertility specialists are trained in advanced genetic screening and IVF techniques.
   
• Advanced Genetic Lab Partners
  We work with accredited labs using the latest PGTA technologies, ensuring accurate results and improved success rates.
   
• Patient-Centric Approach
  From counseling to embryo transfer, we provide compassionate, transparent care at every step.